Milrinone in the treatment of chronic cardiac failure: A controlled trial
- 1 November 1985
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 110 (5) , 1035-1042
- https://doi.org/10.1016/0002-8703(85)90206-6
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Evaluating the efficacy of new inotropic agentsJournal of the American College of Cardiology, 1984
- High-performance liquid chromatographic analysis of milrinone in plasma and urine : Intravenous pharmacokinetics in the dogJournal of Chromatography B: Biomedical Sciences and Applications, 1983
- Vasodilator and inotropic therapy for severe chronic heart failure: Passion and skepticismJournal of the American College of Cardiology, 1983
- Evaluation of a New Bipyridine Inotropic Agent — Milrinone — in Patients with Severe Congestive Heart FailureNew England Journal of Medicine, 1983
- Long-term therapy with a new cardiotonic agent, WIN 47203: Drug-dependent improvement in cardiac performance and progression of the underlying diseaseJournal of the American College of Cardiology, 1983
- Sustained hemodynamic and clinical effects of a new cardiotonic agent, WIN 47203, in patients with severe congestive heart failure.Circulation, 1983
- Failure of dobutamine to increase exercise capacity despite hemodynamic improvement in severe chronic heart failureThe American Journal of Cardiology, 1983
- Pirbuterol, an oral beta-adrenergic receptor agonist, in the treatment of chronic cardiac failure.Circulation, 1982
- Oxygen utilization and ventilation during exercise in patients with chronic cardiac failure.Circulation, 1982
- The epidemiology of cardiac failureJournal of Chronic Diseases, 1965